Home »
Rulemaking » Comment submitted by Alice E. Till, Vice President, Scientific and Technical Affairs, Pharmaceutical Research and Manufacturers of America (PhRMA)
Comment submitted by Alice E. Till, Vice President, Scientific and Technical Affairs, Pharmaceutical Research and Manufacturers of America (PhRMA)
Document ID: EPA-HQ-OAR-2007-0384-0011
Document Type: Public Submission
Agency: Environmental Protection Agency
Received Date: November 15 2007, at 11:58 AM Eastern Standard Time
Date Posted: November 17 2007, at 12:00 AM Eastern Standard Time
Comment Start Date: September 13 2007, at 12:00 AM Eastern Standard Time
Comment Due Date: November 13 2007, at 11:59 PM Eastern Standard Time
Comment submitted by Alice E. Till, Vice President, Scientific and Technical Affairs, Pharmaceutical Research and Manufacturers of America (PhRMA)
Title: Comment submitted by Alice E. Till, Vice President, Scientific and Technical Affairs, Pharmaceutical Research and Manufacturers of America (PhRMA)
View Attachment:
Comment submitted by Alice E. Till, Vice President, Scientific and Technical Affairs, Pharmaceutical Research and Manufacturers of America (PhRMA) (2)
Title: Comment submitted by Alice E. Till, Vice President, Scientific and Technical Affairs, Pharmaceutical Research and Manufacturers of America (PhRMA) (2)
Comment submitted by Alice E. Till, Vice President, Scientific and Technical Affairs, Pharmaceutical Research and Manufacturers of America (PhRMA)
This is comment on Proposed Rule
Protection of Stratospheric Ozone: Extension of Global Laboratory and Analytical Use Exemption for Essential Class I Ozone-Depleting Substances
Attachments:
Comment submitted by Alice E. Till, Vice President, Scientific and Technical Affairs, Pharmaceutical Research and Manufacturers of America (PhRMA)
Title:
Comment submitted by Alice E. Till, Vice President, Scientific and Technical Affairs, Pharmaceutical Research and Manufacturers of America (PhRMA)
Comment submitted by Alice E. Till, Vice President, Scientific and Technical Affairs, Pharmaceutical Research and Manufacturers of America (PhRMA) (2)
Title:
Comment submitted by Alice E. Till, Vice President, Scientific and Technical Affairs, Pharmaceutical Research and Manufacturers of America (PhRMA) (2)
Related Comments
Public Submission Posted: 09/14/2007 ID: EPA-HQ-OAR-2007-0384-0008
Nov 13,2007 11:59 PM ET
Public Submission Posted: 11/14/2007 ID: EPA-HQ-OAR-2007-0384-0009
Nov 13,2007 11:59 PM ET
Public Submission Posted: 11/14/2007 ID: EPA-HQ-OAR-2007-0384-0010
Nov 13,2007 11:59 PM ET
Public Submission Posted: 11/17/2007 ID: EPA-HQ-OAR-2007-0384-0011
Nov 13,2007 11:59 PM ET